<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37112866</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Thrombophilia and Immune-Related Genetic Markers in Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">885</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15040885</ELocationID><Abstract><AbstractText>Aiming to evaluate the role of ten functional polymorphisms in long COVID, involved in major inflammatory, immune response and thrombophilia pathways, a cross-sectional sample composed of 199 long COVID (LC) patients and a cohort composed of 79 COVID-19 patients whose follow-up by over six months did not reveal any evidence of long COVID (NLC) were investigated to detect genetic susceptibility to long COVID. Ten functional polymorphisms located in thrombophilia-related and immune response genes were genotyped by real time PCR. In terms of clinical outcomes, LC patients presented higher prevalence of heart disease as preexistent comorbidity. In general, the proportions of symptoms in acute phase of the disease were higher among LC patients. The genotype AA of the interferon gamma (<i>IFNG</i>) gene was observed in higher frequency among LC patients (60%; <i>p</i> = 0.033). Moreover, the genotype CC of the methylenetetrahydrofolate reductase (<i>MTHFR</i>) gene was also more frequent among LC patients (49%; <i>p</i> = 0.045). Additionally, the frequencies of LC symptoms were higher among carriers of <i>IFNG</i> genotypes AA than among non-AA genotypes (Z = 5.08; <i>p</i> &lt; 0.0001). Two polymorphisms were associated with LC in both inflammatory and thrombophilia pathways, thus reinforcing their role in LC. The higher frequencies of acute phase symptoms among LC and higher frequency of underlying comorbidities might suggest that acute disease severity and the triggering of preexisting condition may play a role in LC development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Rosilene</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8913-2971</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sarges</LastName><ForeName>Kevin Matheus Lima</ForeName><Initials>KML</Initials><Identifier Source="ORCID">0000-0003-0776-6212</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantanhede</LastName><ForeName>Marcos Henrique Damasceno</ForeName><Initials>MHD</Initials><Identifier Source="ORCID">0000-0003-2263-8403</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Fl&#xe1;via P&#xf3;voa</ForeName><Initials>FP</Initials><Identifier Source="ORCID">0000-0002-5667-0754</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Erika Ferreira</ForeName><Initials>EF</Initials><Identifier Source="ORCID">0000-0001-9188-1066</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Fab&#xed;ola Brasil Barbosa</ForeName><Initials>FBB</Initials><Identifier Source="ORCID">0000-0002-4294-4099</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nazar&#xe9; do Socorro de Almeida Viana</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Meira Leite</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3620-3470</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Andr&#xe9;a Luciana Soares</ForeName><Initials>ALS</Initials><Identifier Source="ORCID">0000-0003-4299-0252</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Clinical Analysis, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Brito</LastName><ForeName>Mioni Thieli Magalh&#xe3;es</ForeName><Initials>MTM</Initials><Identifier Source="ORCID">0000-0001-8165-8629</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Clinical Analysis, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Torres</LastName><ForeName>Maria Karoliny</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-5894-304X</Identifier><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Maria Alice Freitas</ForeName><Initials>MAF</Initials><Identifier Source="ORCID">0000-0003-2014-2770</Identifier><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallinoto</LastName><ForeName>Izaura Maria Vieira Cayres</ForeName><Initials>IMVC</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Daniele Freitas</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Section of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Secretary of Health Surveillance, Ministry of Health of Brazil, Ananindeua 67000-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Carla Pinheiro</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Section of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Secretary of Health Surveillance, Ministry of Health of Brazil, Ananindeua 67000-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Giselle Maria Rachid</ForeName><Initials>GMR</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malaria Basic Research Laboratory, Parasitology Section, Evandro Chagas Institute, Health Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua 67000-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio Sim&#xf5;es</ForeName><Initials>JAS</Initials><Identifier Source="ORCID">0000-0002-6267-9966</Identifier><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio Magno</ForeName><Initials>LFM</Initials><Identifier Source="ORCID">0000-0001-8391-2694</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallinoto</LastName><ForeName>Antonio Carlos Ros&#xe1;rio</ForeName><Initials>ACR</Initials><Identifier Source="ORCID">0000-0003-1135-6507</Identifier><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Eduardo Jos&#xe9; Melo</ForeName><Initials>EJM</Initials><Identifier Source="ORCID">0000-0001-5134-5648</Identifier><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Clinical Analysis, Federal University of Par&#xe1;, Bel&#xe9;m 58255-000, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="Y">Thrombophilia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IFNG</Keyword><Keyword MajorTopicYN="N">MTHFR</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">polymorphisms</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors declare that there were no conflicts of interest in conducting this project.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37112866</ArticleId><ArticleId IdType="pmc">PMC10143911</ArticleId><ArticleId IdType="doi">10.3390/v15040885</ArticleId><ArticleId IdType="pii">v15040885</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marco Cascella A., Rajnik M., Cuomo A., Dulebohn S.C., di Napoli R. Italy Uniformed Services Un of the Health Sc Istituto Nazionale Tumori-IRCCS-Fondazione Pascale.  [(accessed on 18 February 2023)];2020  Available online:  https://pubmed.ncbi.nlm.nih.gov/32150360/</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x201c;The Long Tail of COVID-19&#x201d;&#x2014;The Detection of a Prolonged Inflammatory Response after a SARS-CoV-2 Infection in Asymptomatic and Mildly Affected Patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>del Rio C., Collins L.F., Malani P. Long-Term Health Consequences of COVID-19. JAMA&#x2014;J. Am. Med. Assoc. 2020;324:1723&#x2013;1724. doi: 10.1001/jama.2020.19719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological Sequelae of Long-Haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of Post-Acute COVID-19 in Primary Care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. 2020.  [(accessed on 4 February 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Long Covid Could Be Four Different Syndromes, Review Suggests. BMJ. 2020;371:m3981. doi: 10.1136/bmj.m3981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3981</ArticleId><ArticleId IdType="pubmed">33055076</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Piazza M., Boner A.L., Bellanti J.A. Long COVID: A Proposed Hypothesis-Driven Model of Viral Persistence for the Pathophysiology of the Syndrome. Allergy Asthma Proc. 2022;43:187&#x2013;193. doi: 10.2500/aap.2022.43.220018.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P.F.M.D., Lima S.S., Lopes J.D.C., Torres M.K.D.S., Vallinoto I.M.V.C., Bichara C.D.A., Santos E.F.D., de Brito M.T.F.M., da Silva A.L.S., et al. Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front Cell Infect. Microbiol. 2022;12 doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Arendt-Nielsen L., D&#xed;az-Gil G., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Palomar-Gallego M.A., Pellicer-Valero O.J., Giordano R. ACE1 Rs1799752 Polymorphism Is Not Associated with Long-COVID Symptomatology in Previously Hospitalized COVID-19 Survivors. J. Infect. 2022;86:e67&#x2013;e69. doi: 10.1016/j.jinf.2022.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.026</ArticleId><ArticleId IdType="pmc">PMC9794395</ArticleId><ArticleId IdType="pubmed">36584771</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Organization W. Guideline Clinical Management of COVID-19 Patients: Living Guideline, 18 November 2021. 2021.  [(accessed on 20 February 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2.</Citation></Reference><Reference><Citation>Little J., Higgins J.P.T., Ioannidis J.P.A., Moher D., Gagnon F., von Elm E., Khoury M.J., Cohen B., Davey-Smith G., Grimshaw J., et al. STrengthening the REporting of Genetic Association Studies (STREGA)-an Extension of the Strobe Statement. PLoS Med. 2009;6:0151&#x2013;0163. doi: 10.1371/journal.pmed.1000022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000022</ArticleId><ArticleId IdType="pmc">PMC2634792</ArticleId><ArticleId IdType="pubmed">19192942</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., Yin W., Napoleon M.A., Suder E.L., Berrigan J., Zhao Q., Olejnik J., Chandler K.B., Xia C., Feldman J., et al. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent. Sci. 2021;7:1156&#x2013;1165. doi: 10.1021/acscentsci.0c01537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01537</ArticleId><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso H.W., Ip W.K., Chong W.P., Tam C.M., Chiang A.K.S., Lau Y.L. Association of Interferon Gamma and Interleukin 10 Genes with Tuberculosis in Hong Kong Chinese. Genes Immun. 2005;6:358&#x2013;363. doi: 10.1038/sj.gene.6364189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364189</ArticleId><ArticleId IdType="pubmed">15815688</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde S.R.S., Feitosa R.N.M., Freitas F.B., Hermes R.B., Demachki S., Ara&#xfa;jo M.T.F., Soares M.C.P., Ishak R., Vallinoto A.C.R. Association of Cytokine Gene Polymorphisms and Serum Concentrations with the Outcome of Chronic Hepatitis, B. Cytokine. 2013;61:940&#x2013;944. doi: 10.1016/j.cyto.2013.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2013.01.004</ArticleId><ArticleId IdType="pubmed">23395388</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina T.S., Costa S.P., Oliveira M.D., Ventura A.M., Souza J.M., Gomes T.F., Vallinoto A.C.R., P&#xf3;voa M.M., Silva J.S., Cunha M.G. Increased Interleukin-10 and Interferon-Levels in Plasmodium Vivax Malaria Suggest a Reciprocal Regulation Which Is Not Altered by IL-10 Gene Promoter Polymorphism. Malar. J. 2011;10:264. doi: 10.1186/1475-2875-10-264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2875-10-264</ArticleId><ArticleId IdType="pmc">PMC3196927</ArticleId><ArticleId IdType="pubmed">21917128</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago A.M., da Silva Gra&#xe7;a Amoras E., Queiroz M.A.F., da Silva Conde S.R.S., Cayres-Vallinoto I.M.V., Ishak R., Vallinoto A.C.R. TNFA -308G&gt;A and IL10 -1082A&gt;G Polymorphisms Seem to Be Predictive Biomarkers of Chronic HCV Infection. BMC Infect. Dis. 2021;21:s12879&#x2013;s021. doi: 10.1186/s12879-021-06835-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06835-9</ArticleId><ArticleId IdType="pmc">PMC8567538</ArticleId><ArticleId IdType="pubmed">34732154</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa H.P.M., Martins L.C., dos Santos S.E.B., Demachki S., Assump&#xe7;&#xe3;o M.B., Arag&#xe3;o C.D., de Oliveira Corvelo T.C. Interleukin-1 and TNF-&#x3b1; Polymorphisms and Helicobacter Pylori in a Brazilian Amazon Population. World J. Gastroenterol. 2009;15:1465&#x2013;1471. doi: 10.3748/wjg.15.1465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.15.1465</ArticleId><ArticleId IdType="pmc">PMC2665140</ArticleId><ArticleId IdType="pubmed">19322919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Brito W.B., Queiroz M.A.F., da Silva Gra&#xe7;a Amoras E., Lima S.S., da Silva Conde S.R.S., dos Santos E.J.M., Cayres-Vallinoto I.M.V., Ishak R., Vallinoto A.C.R. The TGFB1 -509C/T Polymorphism and Elevated TGF-&#x392;1 Levels Are Associated with Chronic Hepatitis C and Cirrhosis. Immunobiology. 2020;225:152002. doi: 10.1016/j.imbio.2020.152002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2020.152002</ArticleId><ArticleId IdType="pubmed">32962821</ArticleId></ArticleIdList></Reference><Reference><Citation>Keiko Nascimento Yoshioka F., G&#xf3;es Ara&#xfa;jo A., Haydee Tavella M., Guerreiro Hamoy I., Farias Guerreiro J. Prevalence of Hereditary Risk Factors for Thrombophilia in Bel&#xe9;m, Brazilian Amazon. Genet. Mol. Biol. 2006;29:38&#x2013;40. doi: 10.1590/S1415-47572006000100007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1415-47572006000100007</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Santiago A.M., Moura T.C.F., Amoras E.D.S.G., Conde S.R.S.D.S., Cayres-Vallinoto I.M.V., Ishak R., Vallinoto A.C.R. The IL6-174G/C Polymorphism Associated with High Levels of IL-6 Contributes to HCV Infection, but Is Not Related to HBV Infection, in the Amazon Region of Brazil. Viruses. 2022;14:507. doi: 10.3390/v14030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030507</ArticleId><ArticleId IdType="pmc">PMC8950165</ArticleId><ArticleId IdType="pubmed">35336914</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L.F.D., Lima C.P.S.D., Azevedo R.D.S.S., Mendon&#xe7;a D.S.F.D., Rodrigues S.G., Carvalho V.L., Pinto E.V., Maia A.L., Maia M.H.T., Vasconcelos J.M., et al. Polymorphism of DC-SIGN (CD209) Promoter in Association with Clinical Symptoms of Dengue Fever. Viral Immunol. 2014;27:245&#x2013;249. doi: 10.1089/vim.2013.0119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0119</ArticleId><ArticleId IdType="pubmed">24797508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female Gender Is Associated with Long COVID Syndrome: A Prospective Cohort Study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Falchi A., Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccardo M., Inciardi, Alvin C. Editorial Commentary: Long COVID-19: A Tangled Web of Lungs, Heart, Mind, and Gender. Trends Cardiovasc. Med. 2022;32:18&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525003</ArticleId><ArticleId IdType="pubmed">34678422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester S.V., Rusu R., Chan B., Bellows M., O&#x2019;Keefe C., Nicholson S. Sex Differences in Sequelae from COVID-19 Infection and in Long COVID Syndrome: A Review. Curr. Med. Res. Opin. 2022;38:1391&#x2013;1399. doi: 10.1080/03007995.2022.2081454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: Middle Aged Women Face Greater Risk of Debilitating Long Term Symptoms. BMJ. 2021;372:n829. doi: 10.1136/bmj.n829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-Term Cardiovascular Outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew S.C., Gupta E.D. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism: Epidemiology, Metabolism and the Associated Diseases. Eur J. Med. Genet. 2015;58:1&#x2013;10. doi: 10.1016/j.ejmg.2014.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2014.10.004</ArticleId><ArticleId IdType="pubmed">25449138</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadows D.N., Pyzik M., Wu Q., Torre S., Gros P., Vidal S.M., Rozen R. Increased Resistance to Malaria in Mice with Methylenetetrahydrofolate Reductase (Mthfr) Deficiency Suggests a Mechanism for Selection of the MTHFR 677C&gt;T (c.665C&gt;T) Variant. Hum. Mutat. 2014;35:594&#x2013;600. doi: 10.1002/humu.22533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22533</ArticleId><ArticleId IdType="pubmed">24616178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers T.J., Orsomando G., de La Garza R.D., Scott D.A., Kang S.O., Hanson A.D., Beverley S.M. Biochemical and Genetic Analysis of Methylenetetrahydrofolate Reductase in Leishmania Metabolism and Virulence. J. Biol. Chem. 2006;281:38150&#x2013;38158. doi: 10.1074/jbc.M608387200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608387200</ArticleId><ArticleId IdType="pubmed">17032644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajiesmaeil M., Tafvizi F., Sarmadi S. The Effect of Methylenetetrahydrofolate Reductase Polymorphisms on Susceptibility to Human Papilloma Virus Infection and Cervical Cancer. Infect. Genet. Evol. 2016;46:1&#x2013;6. doi: 10.1016/j.meegid.2016.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2016.10.012</ArticleId><ArticleId IdType="pubmed">27771518</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodil-Cornu N., Kozij N., Wu Q., Rozen R., Vidal S.M. Methylenetetrahydrofolate Reductase (MTHFR) Deficiency Enhances Resistance against Cytomegalovirus Infection. Genes Immun. 2009;10:662&#x2013;666. doi: 10.1038/gene.2009.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.50</ArticleId><ArticleId IdType="pubmed">19609317</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba H., Bouqdayr M., Saih A., Bensghir R., Ouladlahsen A., Sodqi M., Marih L., Zaidane I., Kettani A., Abidi O., et al. Association between Methylene-Tetrahydrofolate Reductase C677T Polymorphism and Human Immunodeficiency Virus Type 1 Infection in Morocco. Lab. Med. 2023;54:23&#x2013;29. doi: 10.1093/labmed/lmac081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/labmed/lmac081</ArticleId><ArticleId IdType="pubmed">36036632</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakus N., Duygu F., Rustemoglu A., Yigit S. Methylene-Tetrahydrofolate Reductase Gene C677T and A1298C Polymorphisms as a Risk Factor for Crimean-Congo Hemorrhagic Fever. Nucleosides Nucleotides Nucleic Acids. 2022;41:878&#x2013;890. doi: 10.1080/15257770.2022.2085296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15257770.2022.2085296</ArticleId><ArticleId IdType="pubmed">35666819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronowicki J.P., Abdelmouttaleb I., Peyrin-Biroulet L., Venard V., Khiri H., Chabi N., Amouzou E.K., Barraud H., Halfon P., Sanni A., et al. Methylenetetrahydrofolate Reductase 677 T Allele Protects against Persistent HBV Infection in West Africa. J. Hepatol. 2008;48:532&#x2013;539. doi: 10.1016/j.jhep.2007.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2007.11.017</ArticleId><ArticleId IdType="pubmed">18222012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Pastorino L., Manfredini M., Ozben T., Oliva G., Kaleci S., Iannella R., Tomasi A. COVID-19 Spreading across World Correlates with C677T Allele of the Methylenetetrahydrofolate Reductase (MTHFR) Gene Prevalence. J. Clin. Lab. Anal. 2021;35:e23798. doi: 10.1002/jcla.23798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23798</ArticleId><ArticleId IdType="pmc">PMC8209953</ArticleId><ArticleId IdType="pubmed">34061414</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-Acute COVID-19 Syndrome. Incidence and Risk Factors: A Mediterranean Cohort Study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Ding X., Deng J., Lu Y., Matsuda Z., Thiel A., Chen J., Deng H., Qin Z. Interferon-Gamma Negatively Regulates Th17-Mediated Immunopathology during Mouse Hepatitis Virus Infection. J. Mol. Med. 2011;89:399&#x2013;409. doi: 10.1007/s00109-010-0711-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-010-0711-5</ArticleId><ArticleId IdType="pmc">PMC7079994</ArticleId><ArticleId IdType="pubmed">21191565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., Monticelli S., Lanzavecchia A., Sallusto F. Pathogen-Induced Human T H17 Cells Produce IFN-&#x3b3; or IL-10 and Are Regulated by IL-1&#x3b2;. Nature. 2012;484:514&#x2013;518. doi: 10.1038/nature10957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10957</ArticleId><ArticleId IdType="pubmed">22466287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kak G., Raza M., Tiwari B.K. Interferon-Gamma (IFN-&#x3b3;): Exploring Its Implications in Infectious Diseases. Biomol. Concepts. 2018;9:64&#x2013;79. doi: 10.1515/bmc-2018-0007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bmc-2018-0007</ArticleId><ArticleId IdType="pubmed">29856726</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirault J., Polyzos K.A., Petri M.H., Ketelhuth D.F.J., B&#xe4;ck M., Hansson G.K. The Inflammatory Cytokine Interferon-Gamma Inhibits Sortilin-1 Expression in Hepatocytes via the JAK/STAT Pathway. Eur. J. Immunol. 2017;47:1918&#x2013;1924. doi: 10.1002/eji.201646768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646768</ArticleId><ArticleId IdType="pubmed">28742217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitok K.A., Keller M.P., Attie A.D. Sorting through the Extensive and Confusing Roles of Sortilin in Metabolic Disease. J. Lipid. Res. 2022;63:100243. doi: 10.1016/j.jlr.2022.100243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2022.100243</ArticleId><ArticleId IdType="pmc">PMC9356209</ArticleId><ArticleId IdType="pubmed">35724703</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Azevedo V.N., Amoras E.D.S.G., Moura T.C.F., Guimar&#xe3;es Ishak M.D.O., Ishak R., Vallinoto A.C.R., Martins Feitosa R.N. IFNG +874A/T Polymorphism among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis. Front. Microbiol. 2018;9:795. doi: 10.3389/fmicb.2018.00795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00795</ArticleId><ArticleId IdType="pmc">PMC5968086</ArticleId><ArticleId IdType="pubmed">29867783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro P.A.S., Assone T., Prates G., Tedeschi M.R.M., Fonseca L.A.M., Casseb J. The Role of IFN-&#x3b3; Production during Retroviral Infections: An Important Cytokine Involved in Chronic Inflammation and Pathogenesis. Rev. Inst. Med. Trop. Sao Paulo. 2022;64 doi: 10.1590/s1678-9946202264064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1678-9946202264064</ArticleId><ArticleId IdType="pmc">PMC9528752</ArticleId><ArticleId IdType="pubmed">36197425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P., Garc&#xed;a J., Comach G., Vahey M.T., Wang Z., Forshey B.M., Morrison A.C., Sierra G., Bazan I., Rocha C., et al. Sequential Waves of Gene Expression in Patients with Clinically Defined Dengue Illnesses Reveal Subtle Disease Phases and Predict Disease Severity. PLoS Negl. Trop. Dis. 2013;7:e2298. doi: 10.1371/journal.pntd.0002298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002298</ArticleId><ArticleId IdType="pmc">PMC3708824</ArticleId><ArticleId IdType="pubmed">23875036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>